Ziwig
the French biotech Ziwig built the first salivary endometriosis test, sequencing 109 salivary miRNA markers and decoding them with AI; France granted fast-track reimbursement for 25,000 patients across 80 medical centres in February 2025,…
- Country
- France
CE-IVD Class C
Endometriosis diagnostic
eu
Coverage
| CN | EU | US | |
|---|---|---|---|
| regenerative-personalized | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| FemTech biotech & women's health | regenerative-personalized | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.